| Dr Joshua Michael Jacquet, MD | |
|
400 Wabash Ave, Akron General Medical Center, Akron, OH 44307-2433 | |
| (330) 344-6000 | |
| Not Available |
| Full Name | Dr Joshua Michael Jacquet |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 18 Years |
| Location | 400 Wabash Ave, Akron, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952503930 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 57-012126 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Akron General Medical Center | Akron, OH | Hospital |
| Lodi Community Hospital | Lodi, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Partners Physician Group | 4183529340 | 488 |
News Archive
Osiris Therapeutics, Inc., the leading stem cell company focused on developing and commercializing products to treat medical conditions in inflammatory, cardiovascular, orthopedic, and wound healing markets, announced today its results for the first quarter ended March 31, 2012.
Patients with normal left ventricular function who undergo elective unprotected left main coronary artery (ULMCA) percutaneous coronary intervention (PCI) with drug-eluting stents (DES) had favorable outcomes according to new research. Results of the multicenter, retrospective study are reported in the June issue of Catheterization and Cardiovascular Interventions, a journal published by Wiley-Blackwell on behalf of The Society for Cardiovascular Angiography and Interventions (SCAI).
In an attempt to correct defects in the energy generation that contribute to poor pump function among heart failure patients, researchers examined whether the diabetes drug liraglutide, could improve the condition of patients with advanced heart failure.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
The Associated Press examines rhetoric and reality in the case of a Canadian who came to the U.S. for health care.
› Verified 8 days ago
| Entity Name | Partners Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841239274 PECOS PAC ID: 4183529340 Enrollment ID: O20031202000183 |
News Archive
Osiris Therapeutics, Inc., the leading stem cell company focused on developing and commercializing products to treat medical conditions in inflammatory, cardiovascular, orthopedic, and wound healing markets, announced today its results for the first quarter ended March 31, 2012.
Patients with normal left ventricular function who undergo elective unprotected left main coronary artery (ULMCA) percutaneous coronary intervention (PCI) with drug-eluting stents (DES) had favorable outcomes according to new research. Results of the multicenter, retrospective study are reported in the June issue of Catheterization and Cardiovascular Interventions, a journal published by Wiley-Blackwell on behalf of The Society for Cardiovascular Angiography and Interventions (SCAI).
In an attempt to correct defects in the energy generation that contribute to poor pump function among heart failure patients, researchers examined whether the diabetes drug liraglutide, could improve the condition of patients with advanced heart failure.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
The Associated Press examines rhetoric and reality in the case of a Canadian who came to the U.S. for health care.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joshua Michael Jacquet, MD 242 Calicoe Dr, Akron, OH 44307-2213 Ph: () - | Dr Joshua Michael Jacquet, MD 400 Wabash Ave, Akron General Medical Center, Akron, OH 44307-2433 Ph: (330) 344-6000 |
News Archive
Osiris Therapeutics, Inc., the leading stem cell company focused on developing and commercializing products to treat medical conditions in inflammatory, cardiovascular, orthopedic, and wound healing markets, announced today its results for the first quarter ended March 31, 2012.
Patients with normal left ventricular function who undergo elective unprotected left main coronary artery (ULMCA) percutaneous coronary intervention (PCI) with drug-eluting stents (DES) had favorable outcomes according to new research. Results of the multicenter, retrospective study are reported in the June issue of Catheterization and Cardiovascular Interventions, a journal published by Wiley-Blackwell on behalf of The Society for Cardiovascular Angiography and Interventions (SCAI).
In an attempt to correct defects in the energy generation that contribute to poor pump function among heart failure patients, researchers examined whether the diabetes drug liraglutide, could improve the condition of patients with advanced heart failure.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
The Associated Press examines rhetoric and reality in the case of a Canadian who came to the U.S. for health care.
› Verified 8 days ago
Dr. Jason Dean Eidahl, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 525 E Market St, Akron, OH 44304 Phone: 330-375-3000 | |
Sharhabeel Jwayyed, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 525 E Market St, Akron, OH 44304 Phone: 330-375-3369 Fax: 330-375-3769 | |
Ryan James Reichert, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1 Perkins Square, Akron Childrens Hospital, Akron, OH 44302 Phone: 330-543-1000 | |
Jack H Mitstifer, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 Wabash Ave, Akron, OH 44307 Phone: 330-344-1799 Fax: 330-253-8293 | |
Mary Jo Mcmullen, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 400 Wabash Ave, Akron, OH 44307 Phone: 330-344-1799 Fax: 330-253-8293 | |
Carlynn Fulp, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Akron General Ave, Akron, OH 44307 Phone: 330-344-6000 | |
Gregory Mancini, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Akron General Ave, Akron, OH 44307 Phone: 330-344-6000 |